☰

William T. Senapedis, Ph.D. - Publications

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 
Area:
Intracellular Compartmentation
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Li N, Lopez MA, Linares M, Kumar S, Oliva S, Martinez-Lopez J, Xu L, Xu Y, Perini T, Senapedis W, Baloglu E, Shammas MA, Hunter ZR, Anderson KC, Treon SP, et al. Dual PAK4-NAMPT inhibition impacts growth and survival, and increases sensitivity to DNA-damaging agents in Waldenstrom Macroglobulinemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30206161 DOI: 10.1158/1078-0432.CCR-18-1776  0.324
2018 Kashyap T, Argueta C, Unger T, Klebanov B, Debler S, Senapedis W, Crochiere ML, Lee MS, Kauffman M, Shacham S, Landesman Y. Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents. Oncotarget. 9: 30773-30786. PMID 30112106 DOI: 10.18632/oncotarget.25637  0.404
2014 Gravina GL, Senapedis W, McCauley D, Baloglu E, Shacham S, Festuccia C. Nucleo-cytoplasmic transport as a therapeutic target of cancer. Journal of Hematology & Oncology. 7: 85. PMID 25476752 DOI: 10.1186/s13045-014-0085-1  0.321
2011 Senapedis WT, Kennedy CJ, Boyle PM, Silver PA. Whole genome siRNA cell-based screen links mitochondria to Akt signaling network through uncoupling of electron transport chain. Molecular Biology of the Cell. 22: 1791-805. PMID 21460183 DOI: 10.1091/Mbc.E10-10-0854  0.516
2010 Aldaye FA, Senapedis WT, Silver PA, Way JC. A structurally tunable DNA-based extracellular matrix. Journal of the American Chemical Society. 132: 14727-9. PMID 20925350 DOI: 10.1021/Ja105431H  0.376
2010 Gómez-Baldó L, Schmidt S, Maxwell CA, Bonifaci N, Gabaldón T, Vidalain PO, Senapedis W, Kletke A, Rosing M, Barnekow A, Rottapel R, Capellá G, Vidal M, Astrinidis A, Piekorz RP, et al. TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle (Georgetown, Tex.). 9: 1143-55. PMID 20237422 DOI: 10.4161/Cc.9.6.11018  0.444
2006 Astrinidis A, Senapedis W, Henske EP. Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner Human Molecular Genetics. 15: 287-297. PMID 16339216 DOI: 10.1093/Hmg/Ddi444  0.38
2003 Astrinidis A, Senapedis W, Coleman TR, Henske EP. Cell Cycle-regulated Phosphorylation of Hamartin, the Product of the Tuberous Sclerosis Complex 1 Gene, by Cyclin-dependent Kinase 1/Cyclin B Journal of Biological Chemistry. 278: 51372-51379. PMID 14551205 DOI: 10.1074/Jbc.M303956200  0.336
2002 Khare L, Astrinidis A, Senapedis W, Adams PD, Henske EP. Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells Journal of Medical Genetics. 39: 676-680. PMID 12205112 DOI: 10.1136/Jmg.39.9.676  0.383
Show low-probability matches.